Summit Therapeutics
SMMT
#1266
Rank
HK$110.35 B
Marketcap
HK$149.64
Share price
1.47%
Change (1 day)
637.23%
Change (1 year)

Revenue for Summit Therapeutics (SMMT)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of HK$5.5 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Summit Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A-100%
2022 HK$5.5 M-60.95%
2021 HK$14.1 M
2019 HK$11.27 M-98.13%
2018 HK$0.60 B212.4%
2017 HK$0.19 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$12.73 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.89 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.36 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA